|
1
|
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.
|
Clin Microbiol Infect
|
2012
|
4.68
|
|
2
|
Identification and screening of carbapenemase-producing Enterobacteriaceae.
|
Clin Microbiol Infect
|
2012
|
3.58
|
|
3
|
VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals.
|
J Clin Microbiol
|
2003
|
2.98
|
|
4
|
Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).
|
Antimicrob Agents Chemother
|
1996
|
2.74
|
|
5
|
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.
|
Antimicrob Agents Chemother
|
1997
|
2.05
|
|
6
|
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.
|
J Antimicrob Chemother
|
2001
|
1.60
|
|
7
|
Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
|
J Antimicrob Chemother
|
2006
|
1.58
|
|
8
|
Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.
|
J Clin Microbiol
|
2005
|
1.33
|
|
9
|
Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.
|
Antimicrob Agents Chemother
|
2011
|
1.28
|
|
10
|
Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element.
|
Antimicrob Agents Chemother
|
2005
|
1.18
|
|
11
|
Characterization of In111, a class 1 integron that carries the extended-spectrum beta-lactamase gene blaIBC-1.
|
FEMS Microbiol Lett
|
2003
|
1.10
|
|
12
|
KPC-producing, multidrug-resistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen.
|
Antimicrob Agents Chemother
|
2013
|
1.09
|
|
13
|
Panresistance in VIM-1-producing Klebsiella pneumoniae.
|
J Antimicrob Chemother
|
2005
|
1.07
|
|
14
|
Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147.
|
Antimicrob Agents Chemother
|
2011
|
1.05
|
|
15
|
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
|
Antimicrob Agents Chemother
|
2008
|
1.05
|
|
16
|
Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011.
|
Euro Surveill
|
2012
|
1.01
|
|
17
|
Methicillin-resistant Staphylococcus aureus in the hospitals of central Greece.
|
Int J Antimicrob Agents
|
2001
|
1.01
|
|
18
|
Survey of methicillin-resistant coagulase-negative staphylococci in the hospitals of central Greece.
|
Int J Antimicrob Agents
|
2001
|
0.96
|
|
19
|
Sequence of pR3521, an IncB plasmid from Escherichia coli encoding ACC-4, SCO-1, and TEM-1 beta-lactamases.
|
Antimicrob Agents Chemother
|
2010
|
0.95
|
|
20
|
CTX-m-3 beta-lactamase-producing Escherichia coli from Greece.
|
Microb Drug Resist
|
2002
|
0.94
|
|
21
|
Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model.
|
Clin Microbiol Infect
|
2007
|
0.94
|
|
22
|
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
|
Antimicrob Agents Chemother
|
2010
|
0.93
|
|
23
|
Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
|
FEMS Microbiol Lett
|
2001
|
0.93
|
|
24
|
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.
|
Int J Antimicrob Agents
|
2010
|
0.92
|
|
25
|
Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-β-lactamase.
|
J Antimicrob Chemother
|
2013
|
0.92
|
|
26
|
Emergence of Serratia liquefaciens and Klebsiella oxytoca with metallo-beta-lactamase-encoding IncW plasmids: further spread of the blaVIM-1-carrying integron In-e541.
|
Int J Antimicrob Agents
|
2008
|
0.91
|
|
27
|
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
|
Antimicrob Agents Chemother
|
2007
|
0.89
|
|
28
|
Providencia stuartii with VIM-1 metallo-beta-lactamase.
|
J Antimicrob Chemother
|
2007
|
0.87
|
|
29
|
Detecting VIM-1 production in Proteus mirabilis by an imipenem-dipicolinic acid double disk synergy test.
|
J Clin Microbiol
|
2009
|
0.87
|
|
30
|
Characterization of pKP1433, a novel KPC-2-encoding plasmid from Klebsiella pneumoniae sequence type 340.
|
Antimicrob Agents Chemother
|
2013
|
0.86
|
|
31
|
The first clinical isolates of Enterococcus faecium with the VanA phenotype in a tertiary Greek hospital.
|
J Antimicrob Chemother
|
2000
|
0.86
|
|
32
|
Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study.
|
Gastroenterology
|
1992
|
0.86
|
|
33
|
Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis.
|
Antimicrob Agents Chemother
|
2012
|
0.85
|
|
34
|
Evidence for chromosomal and plasmid location of CMY-2 cephalosporinase gene in Salmonella serotype Typhimurium.
|
J Antimicrob Chemother
|
2008
|
0.84
|
|
35
|
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays.
|
Intervirology
|
1995
|
0.82
|
|
36
|
Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
|
Int J Antimicrob Agents
|
2007
|
0.81
|
|
37
|
Detection of Citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece, July 2011.
|
Euro Surveill
|
2011
|
0.81
|
|
38
|
Evaluation of an anti-PBP 2a slide latex agglutination test in coagulase-negative staphylococci isolated in Greek hospitals.
|
Diagn Microbiol Infect Dis
|
2002
|
0.79
|
|
39
|
Characterization of the US8.5 protein of herpes simplex virus.
|
Arch Virol
|
1995
|
0.79
|
|
40
|
Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS.
|
Antimicrob Agents Chemother
|
2014
|
0.79
|
|
41
|
Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
|
Antimicrob Agents Chemother
|
1998
|
0.78
|
|
42
|
Diversity of beta-lactam resistance levels among related Klebsiella pneumoniae strains isolated in an intensive care unit.
|
J Chemother
|
2000
|
0.78
|
|
43
|
Expression of immunoreactive forms of the hepatitis C NS5A protein in E. coli and their use for diagnostic assays.
|
Arch Virol
|
2002
|
0.77
|
|
44
|
Does it ever make sense to treat a bacterial infection with a drug against which the responsible pathogen possesses a resistance mechanism?
|
Clin Microbiol Infect
|
2011
|
0.75
|
|
45
|
In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
|
Chemotherapy
|
1997
|
0.75
|
|
46
|
Antibody responses to hepatitis C virus by second-generation immunoassays in a cohort of patients with bleeding disorders.
|
Vox Sang
|
1992
|
0.75
|